Research use only · EU-warehoused · COA on every batch · HPLC ≥99% · Shipment 2–5 days
Log in Register
Home/ Catalogue/ Encapsulated Compounds/ BPC-157 Arginate Capsules
In stock
BPC-157 Arginate Capsules

BPC-157 Arginate Capsules

Lyophilised · ≥99% (HPLC) ·

Quantity Volume discounts auto-applied
Custom quantity
1

Supplied lyophilised. Reconstitution typically uses bacteriostatic water.

Independently third-party tested · COA on every batch · 48h EU dispatch
[01]

Overview

BPC-157 Arginate Capsules supply the arginate salt of BPC-157, a stable form of the gastric pentadecapeptide selected for oral-research handling, studied in tendon, ligament, muscle and gastrointestinal repair models. CAS 137525-51-0; molecular formula C62H98N16O22; 60 HPMC vegan capsules at 500 mcg each, ≥99% purity by HPLC. For laboratory research use only.

Buried in the protective chemistry of human gastric juice is a short sequence that proved remarkably hard to break. BPC-157 is a stable synthetic pentadecapeptide derived from that gastric-protection fragment — fifteen residues with an unusual resistance to enzymatic degradation. The arginate salt offered here is a more stable form selected for oral-research handling, and it has become one of the most heavily studied cytoprotective peptides in the regeneration literature.

A pentadecapeptide built around cytoprotection. BPC-157 is studied as a body-protection compound whose effects cluster around angiogenesis and the nitric-oxide system, where it has been framed as maintaining and recovering essential protective functions rather than acting through a single receptor (Sikiric et al., 2025). Reviews continue to position it as an investigational peptide whose translational development hinges on formulation and stability strategies (Mateescu et al., 2026).

Much of its interest comes from breadth: across orthopaedic and sports-medicine research, BPC-157 recurs as a candidate in tendon, ligament and muscle-injury models, where its repair-associated signalling is repeatedly catalogued (Rahman et al., 2026).

What the research explores. Across cell-culture and animal systems, BPC-157 has been investigated along several converging lines:

  • Tendon, ligament & muscle repair — examined in musculoskeletal-injury and muscle-to-bone reattachment paradigms (Matek et al., 2026; Matek et al., 2025).
  • Tissue protection & the nitric-oxide system — studied as a cytoprotectant acting through angiogenic and NO-linked pathways, including fistula and gastrointestinal models (Sikiric et al., 2025; Madzarac et al., 2026).
  • Regeneration & analgesia signalling — explored from tissue repair through to pain-management endpoints in experimental systems (Yuan et al., 2026).

The activity described here is drawn from in-vitro and animal studies; it characterises biological behaviour in experimental models and does not establish efficacy or safety in humans. Full citations are listed under the Scientific References tab.

Physicochemical profile. CAS No. 137525-51-0 · Molecular formula C62H98N16O22 · Molecular weight 1419.55 g/mol · Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (15 aa) · Appearance: White lyophilized powder · Solubility: Soluble in water.

Specification & quality. Each bottle contains 60 HPMC (vegan) capsules, each providing 500mcg of BPC-157 (arginate) at ≥99% (HPLC). Encapsulated — no reconstitution required. Every batch is independently third-party tested, and a Certificate of Analysis (COA) is available. Store at -20°C, protect from light and moisture; shelf life 24 months from the manufacture date. EU warehoused.

This product is intended for laboratory research use only (RUO). It is not a drug, food, cosmetic, or dietary supplement, and is not for human or veterinary use, ingestion, or diagnostic application. Handling is restricted to qualified research professionals operating in an appropriately equipped laboratory.

Supplied for in-vitro laboratory research use only (RUO). Not a drug, food or supplement; not for human or veterinary use.

[04]

Quality & COA

Certificate of Analysis
Lot-specific COA with every order

Certificate of Analysis — lot-specific COA ships with every order and is available on request.

Each lot is tested by an independent third-party laboratory for identity (mass spectrometry) and purity (HPLC). The Certificate of Analysis for your specific batch ships with the order and is available on request — no house data, no exceptions.

HPLC purity
≥99% (HPLC)
Method
HPLC + MS
Endotoxin
Reported
[02]

Data Sheet

CAS number137525-51-0
Molecular formulaC62H98N16O22
Molecular weight1419.55
SequenceGly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (15 aa)
Purity≥99% (HPLC)
Physical formWhite lyophilized powder
Quantity60 capsules
SolubilitySoluble in water
StorageStore at -20°C, protect from light and moisture
ReconstitutionEncapsulated — no reconstitution required.
Shelf life24 months from manufacture date
Dose per capsule500mcg
Capsule materialHPMC (Vegan)
OriginEU · Slovakia
ClassificationResearch use only
[03]

Scientific References

01 Rahman OF, Lee SJ, Seeds WA Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews. 2026;10(1). PMID: 41490200. doi:10.5435/JAAOSGlobal-D-25-00236. PubMed 02 Mayfield CK, Bolia IK, Feingold CL, Lin EH, Liu JN, Rick Hatch GF et al. Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians. The American journal of sports medicine. 2026;54(1):223-229. PMID: 41476424. doi:10.1177/03635465251357593. PubMed 03 Mendias CL, Awan TM Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports medicine (Auckland, N.Z.). 2026. PMID: 41966639. doi:10.1007/s40279-026-02437-0. PubMed 04 Yuan C, Demers A, Silva-Ortiz V, Hasoon JJ, Lee W, Dave K et al. From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management. International journal of molecular sciences. 2026;27(6). PMID: 41898733. doi:10.3390/ijms27062876. PubMed 05 Matek D, Matek I, Japjec M, Matek M, Prenc J, Staresinic B et al. Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone Junction Therapy Perspectives with Growth Factors and Stable Gastric Pentadecapeptide BPC 157-A Review. Pharmaceuticals (Basel, Switzerland). 2026;19(2). PMID: 41754849. doi:10.3390/ph19020309. PubMed 06 Mateescu DM, Gavrilescu DM, Constantinescu FE, Oancea C, Ilie AC, Folescu R et al. BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers. Pharmaceutics. 2026;18(5). PMID: 42198317. doi:10.3390/pharmaceutics18050625. PubMed 07 Grubisic MM, Strbe S, Barisic I, Balenovic D, Stambolija V, Lozic M et al. Stable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in Rats. Current neuropharmacology. 2026. PMID: 41832718. doi:10.2174/011570159X401706251126101531. PubMed 08 Madzarac G, Becejac T, Penovic T, Drazenovic D, Kralj L, Popović Dolic M et al. Tracheocutaneous Fistula Resolved by Pentadecapeptide BPC 157 Therapy Through the NO-System-Triple NO-Agent Approach in Rats. Pharmaceuticals (Basel, Switzerland). 2026;19(1). PMID: 41599743. doi:10.3390/ph19010145. PubMed 09 Lee E, Burgess K Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. Alternative therapies in health and medicine. 2025;31(5):20-24. PMID: 40131143. PubMed 10 Matek D, Matek I, Staresinic E, Japjec M, Bojanic I, Boban Blagaic A et al. Stable Gastric Pentadecapeptide BPC 157 as Therapy After Surgical Detachment of the Quadriceps Muscle from Its Attachments for Muscle-to-Bone Reattachment in Rats. Pharmaceutics. 2025;17(1). PMID: 39861766. doi:10.3390/pharmaceutics17010119. PubMed 11 Whitehouse M Concerning BPC-157, a natural pentadecapeptide, that acts as a cytoprotectant and is believed to protect the gastro-intestinal tract (GIT). Inflammopharmacology. 2025;33(8):4879-4881. PMID: 40759852. doi:10.1007/s10787-025-01882-z. PubMed 12 Sikiric P, Seiwerth S, Skrtic A, Staresinic M, Strbe S, Vuksic A et al. BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. Pharmaceuticals 2025, 18, 185. Pharmaceuticals (Basel, Switzerland). 2025;18(10). PMID: 41155565. doi:10.3390/ph18101450. PubMed 13 Dekker TJ Editorial Commentary: Testosterone, Growth Hormone, and Vitamin D Supplementation Is Not Routinely Indicated for Orthopaedic Surgery Patients. Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association. 2025;41(8):3151-3152. PMID: 39909207. doi:10.1016/j.arthro.2025.01.033. PubMed 14 Józwiak M, Bauer M, Kamysz W, Kleczkowska P Reply to Sikiric et al. BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on "Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. Pharmaceuticals 2025, 18, 185". Pharmaceuticals (Basel, Switzerland). 2025;18(10). PMID: 41155566. doi:10.3390/ph18101451. PubMed 15 Lee E, Walker C, Ayadi B Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study. Alternative therapies in health and medicine. 2024;30(10):12-17. PMID: 39325560. PubMed

References are illustrative of the research literature surrounding this compound. All claims relate to in-vitro and animal models only.

[05]

FAQ

BPC-157 is a stable synthetic pentadecapeptide derived from a protective sequence in human gastric juice, studied as a cytoprotective and regeneration-associated compound acting through angiogenic and nitric-oxide pathways (Sikiric et al., 2025). The arginate salt is a more stable form suited to oral-research handling. Condor Research supplies it strictly as a Research Use Only reference compound for in vitro and animal studies, not for human or veterinary use.

BPC-157 is a 15-residue gastric pentadecapeptide studied around cytoprotection and the nitric-oxide system, whereas TB-500 is a 43-residue thymosin β-4 fragment studied chiefly as an actin-binding regulator of cell migration and angiogenesis. They belong to different peptide classes and answer different research questions about tissue dynamics. Both are supplied strictly as research-use-only reference compounds, not for human or veterinary use.

The arginate salt is selected as a more stable form for oral-research handling, since formulation and stability are recognised as central challenges for this peptide (Mateescu et al., 2026). The underlying 15-amino-acid sequence is identical; the counter-ion supports robustness during research handling. The material is offered solely as a Research Use Only reference compound, not for human or veterinary use.

BPC-157 is a gastric-derived pentadecapeptide studied for cytoprotection and tissue repair across the GI tract and musculoskeletal system, while KPV is a melanocortin-derived tripeptide studied chiefly for anti-inflammatory signalling in intestinal and dermal models. They probe different mechanisms within the broader question of mucosal and tissue response. Each is supplied only as a Research Use Only reference compound, not for human or veterinary use.

Yes. Condor Research supplies BPC-157 strictly as a Research Use Only reference compound to professionals and institutions, not as a medicine, supplement or product for human or veterinary use. Buyers are responsible for confirming import legality in their own country. Questions: info@condorresearch.com.

The capsule is a pre-weighed solid format: 500mcg of BPC-157 arginate sealed in an HPMC (vegan) shell so each unit holds a precise, handling-ready quantity. This removes bench weighing steps and requires no reconstitution. The format is a laboratory convenience only and does not imply or permit human or veterinary consumption — for research use only.

No. The arginate peptide is already encapsulated as a pre-measured solid, so no reconstitution is required for handling. Researchers prepare any working solutions according to their own validated experimental protocols. The capsule is a laboratory format only and is not intended for human or veterinary use.

Each bottle contains 60 HPMC (vegan) capsules, with 500mcg of BPC-157 arginate per capsule at ≥99% (HPLC) purity. Every batch is independently third-party tested and a Certificate of Analysis is available on request. This specification describes a research reference material, not a product for human or veterinary use.

BPC-157 has CAS No. 137525-51-0, molecular formula C62H98N16O22 and a molecular weight of 1419.55 g/mol. It is a 15-amino-acid peptide (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) supplied as a white lyophilized powder, soluble in water. These values are provided for laboratory characterisation and research use only.

Yes. Every BPC-157 batch is tested by an independent third-party laboratory by HPLC for identity and purity (≥99%), and each lot ships with a lot-specific Certificate of Analysis. To request the COA for your batch, contact info@condorresearch.com. This documentation supports research use only, not human or veterinary application.

[06]

Reviews

Leave a review
Earn 250 points for a verified review (account required).
4.7
64 verified reviews
5
78%
4
16%
3
5%
2
2%
1
0%
Apr 2026
Impeccable packaging

Cold-chain handling was respected end to end. Vials arrived sealed, labelled and intact. Documentation is the most thorough I've seen from an EU supplier.

Dr. S. Novak · Private lab · CZ Verified purchase
Mar 2026
Reliable, well documented

Solubility and stability were as described. Knocked one star only because express shipping options are limited, but quality is not in question.

P. Andersson · Research institute · SE Verified purchase
Mar 2026
Reproducible across batches

Third order with Condor. Batch-to-batch variation is minimal, which matters for our longitudinal work. The mono-labelled vials are easy to track.

Dr. R. Costa · Academic lab · PT Verified purchase
Feb 2026
Exactly what research needs

No marketing fluff — just characterised material with paperwork. The data sheet and CAS matched our records precisely.

J. Meijer · Biotech R&D · NL Verified purchase

Related compounds